Genexine, Inc. (KOSDAQ:095700)
South Korea · Delayed Price · Currency is KRW 4,660.00
+85.00 (1.86%)
Mar 20, 2026, 3:30 PM KST
Genexine Market Cap
Genexine has a market cap or net worth of 211.94 billion as of March 20, 2026. Its market cap has increased by 6.15% in one year.
Market Cap
211.94B
Enterprise Value
n/a
Revenue
5.81B
Ranking
n/a
PE Ratio
n/a
Stock Price
4,660.00
Market Cap Chart
Since September 15, 2009, Genexine's market cap has increased from 109.02B to 211.94B, an increase of 94.40%. That is a compound annual growth rate of 4.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 211.94B | -0.53% |
| Dec 30, 2025 | 213.07B | -12.27% |
| Dec 30, 2024 | 242.86B | -40.82% |
| Dec 28, 2023 | 410.35B | -12.73% |
| Dec 29, 2022 | 470.21B | -67.78% |
| Dec 30, 2021 | 1.46T | -52.47% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GC Cell | 398.97B |
| JETEMA, | 319.76B |
| Bioneer | 313.34B |
| HLB Therapeutics | 275.93B |
| Helixmith | 268.91B |
| EASY BIO,Inc. | 229.92B |
| Vaxcell-Bio Therapeutics | 190.01B |
| MedPacto | 183.71B |